Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Exclusivity Provision Surfaces In OTC Monograph Bill

Executive Summary

The House Health subcommittee asks whether allowing manufacturers' periods of US market exclusivity for some approved OTC monograph proposals is needed, or would be fair to consumers.

Advertisement

Related Content

Legislators On OTC Monograph Reform: What Took You So Long?
Legislators On OTC Monograph Reform: What Took You So Long?
Beautycounter-Led Coalition Lobbies For Tighter Cosmetics Regulations
Two-Tier OTC Monograph Approach Could Come With User Fee Revamp
Primatene Mist CRL Underscores Challenges For OTC Asthma Treatments

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

PS121540

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel